<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01013038</url>
  </required_header>
  <id_info>
    <org_study_id>2008B101</org_study_id>
    <nct_id>NCT01013038</nct_id>
  </id_info>
  <brief_title>Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study</brief_title>
  <acronym>TAPAS II</acronym>
  <official_title>Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study (TAPAS II)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Netherlands Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Medical Center Groningen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this trial, the investigators will evaluate the effect of thrombus aspiration followed by
      stent implantation in improving myocardial blush grade in patients with acute
      non-ST-elevation myocardial infarction compared to conventional percutaneous coronary
      intervention (PCI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial
      infarction Study (TAPAS) has shown that thrombus aspiration improves myocardial perfusion and
      clinical outcome compared to conventional primary percutaneous coronary intervention (PCI) in
      patients with ST-segment elevation myocardial infarction. Impaired myocardial perfusion due
      to spontaneous or angioplasty-induced embolization of atherothrombotic material also occurs
      in patients with Non-ST-elevation myocardial infarction (NSTEMI). The aim of this study is to
      determine whether thrombus aspiration before stent implantation will result in improved
      myocardial perfusion in patients with NSTEMI compared to conventional PCI.

      The study is a single-centre, prospective, randomised trial with blinded evaluation of
      endpoints. The planned inclusion is 540 patients with acute NSTEMI who are candidates for
      urgent PCI.

      If thrombus aspiration leads to significant improvement of myocardial perfusion in patients
      with acute NSTEMI it may become part of the standard interventional approach.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2007</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of myocardial blush grade 3 after PCI</measure>
    <time_frame>During PCI procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Coronary angiographic outcomes</measure>
    <time_frame>During PCI procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histopathological outcomes of atherothrombotic material</measure>
    <time_frame>After inclusion is stopped: mean 1 year (storage at -80 degrees Celcius)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Enzymatic infarct size</measure>
    <time_frame>During hospital stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrocardiographic outcomes</measure>
    <time_frame>30 to 60 minutes after PCI</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical outcomes at 30 days and 1 year</measure>
    <time_frame>30 days till 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">540</enrollment>
  <condition>Non-ST-Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Conventional percutaneous coronary intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Thrombus aspiration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thrombus aspiration followed by stent implantation</intervention_name>
    <description>Export aspiration catheter 6F (Medtronics)</description>
    <arm_group_label>Thrombus aspiration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional PCI</intervention_name>
    <description>balloon angioplasty and/or stent implantation</description>
    <arm_group_label>Conventional percutaneous coronary intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of acute NSTEMI defined by

               -  Chest pain suggestive for myocardial ischemia for at least 30 minutes,

               -  Time from onset of symptoms of less than 72 hours

               -  ECG with ST-segment shifts (depression of &gt;0.1 mV in at least two contiguous
                  leads or transient ST-segment elevation &gt;0.1 mV in at least two contiguous leads
                  for less than 30 minutes) and/or T-wave changes (inversion of &gt;0.15 mV in at
                  least two contiguous leads)

               -  Positive cardiac troponin T &gt;0,01 Î¼g/L.

          -  Clinical indication for urgent PCI of the ischemia-related target lesion as identified
             at coronary angiography

        Exclusion Criteria:

          -  Persistent ST-elevation of more than 0.1 mV in 2 or more leads

          -  Presence of cardiogenic shock

          -  Inability to obtain informed consent

          -  Known existence of a life-threatening disease with a life expectancy of less than 6
             months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marthe A Kampinga, MD</last_name>
    <phone>+31503610444</phone>
    <email>m.a.kampinga@thorax.umcg.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Felix Zijlstra, MD PhD</last_name>
    <phone>+31503613238</phone>
    <email>f.zijlstra@thorax.umcg.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marthe A Kampinga, MD</last_name>
      <phone>+31503610444</phone>
      <email>m.a.kampinga@thorax.umcg.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2009</study_first_submitted>
  <study_first_submitted_qc>November 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2009</study_first_posted>
  <last_update_submitted>November 12, 2009</last_update_submitted>
  <last_update_submitted_qc>November 12, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2009</last_update_posted>
  <responsible_party>
    <name_title>Marthe Anna Kampinga, MD &amp; Felix Zijlstra, MD PhD</name_title>
    <organization>University Medical Center Groningen, Thoraxcenter</organization>
  </responsible_party>
  <keyword>myocardial infarction</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>thrombus aspiration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Non-ST Elevated Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

